Today, we will be providing an overview of the latest developments in the field of Infectious Diseases up to April 2024. This includes new medications, new guidelines, and noteworthy research and journal articles that have been published in the first four months of the year. Recent Infectious Diseases-Related Clinical Guidelines Recent Infectious Disease-Related FDA Medication […]
Read More
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Read MoreThe Food and Drug Administration (FDA) protects public health by guaranteeing the safety, effectiveness, and security of pharmaceuticals and medical devices. The Prescription Drug User Fee Act (PDUFA) date marks the deadline by which the FDA must complete its review of drug or device applications. Below, you will find a list of drugs and devices, […]
Read More
In this post, we will be taking a closer look at some of the most popular endocrinology-related articles that have been published during the month of April 2024. The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report 2024 Abridged Diabetes Standards of Care Impact of insulin sensitization […]
Read More
The anticipation is building for Heart Rhythm 2024 (HRS2024), set to take place in Boston from May 16-19, 2024. The society’s annual meeting will delve into the latest groundbreaking research and advancements in the fields of cardiology and electrophysiology (EP). If you have not already done so, we highly recommend registering for the event by […]
Read MoreOn April 22, 2024, the US Food and Drug Administration (FDA) approved ImmunityBio’s first-in-class interleukin-15 superagonist (IL-15) nogapendekin alfa inbakicept-pmln (Anktiva), plus bacillus Calmette-Guérin (BCG), for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors. Designated an FDA Breakthrough Therapy, the novel immunotherapy […]
Read More
As Alcohol Awareness Month unfolds, the imperative to address alcohol-related issues with informed strategies is a critical aspect often overlooked in discussions about alcohol abuse. In this article, we dive into a comprehensive analysis of two major guidelines published by the American Society of Addiction Medicine (ASAM) and the American Psychiatric Association (APA). By comparing […]
Read More
In our previous article, we’ve identified the specific guideline(s) we’re focused on implementing, measured existing practices at the organization, and also identified any potential barriers to implementation, it’s time to focus on determination and prioritization of specific interventions. Interventions may be targeted at one or more stakeholders, including: Strategies for implementation and specific interventions include […]
Read More
The 73rd Annual Scientific Session & Expo of the American College of Cardiology took place from April 6-8, 2024, in Atlanta, GA. This event is a cornerstone for healthcare professionals dedicated to improving patient care and outcomes in the field of cardiology. One of the key topics discussed at ACC24 was heart failure. According to […]
Read More
Missed out on the latest clinical practice guidelines? Here’s a list of all the guidelines and FDA drug approvals that were published during the last month.
Read More